Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Jun. 30, 2011
Current Assets:
Cash	$ 649	$ 725
Accounts receivable, net	1,374	1,405
Inventories	4,740	7,396
Investment in iBio, Inc., restricted	823	823
Other current assets	454	285
Total current assets	8,040	10,634
Property and equipment, net	1,466	1,667
Intangible assets, net	1,188	1,294
Security deposits and other assets	58	55
Total Assets	10,752	13,650
Current Liabilities:
Notes Payable	7,805	7,805
Accounts payable	4,839	7,547
Convertible note payable - CD Financial LLC	4,500	4,500
Accrued expenses and other current liabilities	2,141	1,193
Notes Payable, CD Financial LLC	300	300
Total current liabilities	19,585	21,345
Commitments and Contingencies
Stockholders' Deficiency:
Common Stock, $0.002 par value; 50,000,000 shares authorized; 21,065,074 and 20,915,074 shares issued at March 31, 2012 and June 30, 2011, 21,030,174 and 20,880,174 shares outstanding at March 31, 2012 and June 30, 2011	42	42
Additional paid-in capital	44,564	44,543
Accumulated deficit	(53,340)	(52,181)
Less: Treasury stock, at cost, 34,900 shares	(99)	(99)
Total Stockholders' Deficiency	(8,833)	(7,695)
Total Liabilities and Stockholders' Deficiency	$ 10,752	$ 13,650